Phibro Animal Health | PAHC - 股票

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.06B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	股票	更改		日
Align Technology	USD 228.16M		15.59M	2025-09
ANI Pharmaceuticals	USD 143.07M		3.41M	2025-12
Assertio Holdings	USD 24.76M		8.12M	2025-09
Aurora Cannabis	CAD 230.56M		8.6M	2025-12
Bristol-Myers Squibb	USD 2.76B		21M	2025-09
Canopy Growth	CAD 105.56M		3.18M	2025-12
Corcept Therapeutics	USD 12.87M		519K	2025-12
Eli Lilly	USD 13.74B		1.56B	2025-12
Henry Schein	USD 2B		90M	2025-12
Idexx Laboratories	USD 377.76M		13.81M	2025-12
Knight Therapeutics	CAD 95.4M		2.91M	2024-03
Merck	USD 6.44B		157M	2025-09
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Pacira	USD 152.86M		4.82M	2025-12
Phibro Animal Health	USD 517.35M		45.57M	2025-12
Prestige Brands	USD 163.59M		4.6M	2025-12
Supernus Pharmaceuticals	USD 107.1M		63.08M	2025-09
Zoetis	USD 2.43B		35M	2025-12